News

VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2066 FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION OFFICIALLY INITIATED IN CHINA

October 22, 2026

a261022_01.png

a261022_02.png

Copyright © CSPC PHARMACEUTICAL GROUP LIMITED All Rights Reserved | 冀ICP备05003393号

Wechat